Efferalgan Vitamin C, 20 tablets, Bristol-Myers Squibb

Efferalgan Vitamin C, 20 tablets, Bristol-Myers Squibb

Read the leaflet carefully and completely before you start using this medicine, because it contains important information for you.
Always use this medicine as directed in this leaflet or as directed by your doctor or pharmacist.

Indications:
Efferalgan Vitamine C is indicated in adults and children weighing 25 kg or more (from the age of approximately 8 years) for the symptomatic treatment of mild to moderate pain and/or febrile conditions.

Composition:
What Efferalgan Vitamine C contains
- The active substances are: paracetamol 330 mg, ascorbic acid 200 mg
- The other components: potassium hydrogen carbonate, sodium hydrogen carbonate, sorbitol (E 420), anhydrous citric acid, sodium benzoate (E 211), sodium docusate, povidone.

Administration method:

• Always use this medicine exactly as described in this leaflet or as you have been told
• the doctor or pharmacist. Talk to your doctor or pharmacist if you are not sure.
• The recommended dose is 10 mg/kg body weight to 15 mg/kg body weight every 4 to 6 hours, up to
• maximum total daily dose of 60 mg/kg body weight. The minimum interval between administrations is 4 hours.

Contraindications:
Known hypersensitivity to paracetamol or to propacetamol hydrochloride (paracetamol precursor) or to any of the excipients of this medicine.

Precautions:
Before using Efferalgan Vitamine C, consult your doctor or pharmacist.

Pregnancy, breast-feeding and fertility:
Associated with paracetamol:
Clinical experience regarding the use of paracetamol during pregnancy and breastfeeding is limited.
Task :
Epidemiological data regarding the use of therapeutic doses of paracetamol have not shown any unwanted effects in pregnant women or on the health of the fetus or newborn.
Reproduction studies with orally administered paracetamol have not shown malformations or toxic effects on the fetus.
Prospective data on pregnant women exposed to overdoses of paracetamol did not demonstrate an increased risk of malformations.
However, Efferalgan Vitamine C should not be used during pregnancy unless the benefit/risk ratio has been carefully assessed. In pregnant patients, the recommended dose and duration of administration must be strictly observed.
Breastfeeding:
After oral administration, small amounts of paracetamol are excreted in breast milk. Cases of transient skin rashes have been reported in breast-fed infants. However, paracetamol is considered to be compatible with breastfeeding. However, administer Efferalgan Vitamine C with caution to breastfeeding women.
Associated with vitamin C:
Vitamin C passes from the maternal blood to the fetal blood through an active transport mechanism. Vitamin C is excreted in human breast milk. Limited epidemiological and clinical data do not support any deviation from the dose range of vitamin C provided by taking the recommended daily dose for healthy adults in pregnant and lactating women (see section 4.5 and section 4.9). Given the limited data on high doses of vitamin C during pregnancy and breastfeeding, the use of Efferalgan Vitamine C during pregnancy and breastfeeding is not recommended unless under medical supervision.

Driving vehicles and using machines:
It's not necessary.

Presentation:
20 tablets